Engineered metalloenzymes disrupt chemical synthesis: implications for green chemistry, industrial equity, and biocatalytic scalability
Original framing: “<i>De novo</i> design of enantioselective artificial metalloenzyme photocatalysts” — Nature
The trajectory of synthetic biology mirrors earlier waves of industrial innovation, such as the Green Revolution or the petrochemical boom, which centralized control over life forms in the hands of a few corporations and states. Historical precedents show how 'disruptive' technologies often deepen dependency—e.g., the U.S. and European dominance of agricultural biotech left African farmers reliant on patented seeds. The *Nature* article ignores this pattern by framing biocatalysis as a neutral tool, whereas it is inherently political, shaped by Cold War-era biotech policies and neoliberal IP regimes. The 1970s *Asilomar Conference* debates on genetic engineering offer a parallel: then, as now, the focus on 'safety' masked questions of equity and sovereignty.
The *Nature* article’s celebration of *de novo* artificial metalloenzymes as a scientific breakthrough obscures the deeper systemic question: *whose biocatalytic future are we building, and whose voices are excluded from the design?
* The technology itself is neither inherently green nor equitable—its impact depends on how it integrates into global power structures, from patent regimes that entrench Northern dominance to industrial supply chains that deepen dependency. Historical precedents show that synthetic biology, like earlier waves of industrial innovation, risks reinforcing colonial patterns of extraction and control, unless actively counterbalanced by decentralized, community-led alternatives. The trickster lens reveals the absurdity of framing engineered enzymes as a panacea while ignoring that their production relies on the same fossil-fuel-dependent infrastructure they seek to replace. To avoid repeating the mistakes of the Green Revolution or the petrochemical era, biocatalytic innovation must be rooted in ethical IP reform, cross-cultural co-design, and marginalized-led governance—transforming it from a tool of corporate monopoly into a catalyst for just transition.